About
Cardiologs AI Cardio, now part of Philips, is a pioneering medical-grade AI software platform designed to reinvent cardiology diagnostics through clinically validated deep learning and cloud technology. Built to reduce the growing burden of ECG analysis, it empowers clinicians, hospitals, and cardiac service providers to scale their diagnostic capacity without sacrificing accuracy or speed. At the core of the platform is the Cardiologs Holter solution, the world's first FDA-cleared ECG analysis tool driven by deep learning. With more than 200 million ECGs processed and four patents, the platform has an extensive evidence base—backed by over 20 peer-reviewed publications and clinical abstracts—establishing it as a trusted tool for arrhythmia detection and cardiac diagnostics globally. The platform integrates seamlessly into existing clinical workflows, providing advisory AI-generated interpretations that support, rather than replace, physician judgment. Cardiologists and technicians benefit from automated pre-screening of ECG recordings, significantly reducing manual review time and enabling faster turnaround of diagnoses. Institutions using Cardiologs have reported the ability to triple their Holter activity while delivering quicker results to more patients. Designed for enterprise healthcare settings, Cardiologs AI Cardio is suited for cardiac electrophysiologists, cardiology departments, diagnostic labs, and remote monitoring service providers. Its cloud-based architecture ensures scalability and accessibility across geographies, making advanced cardiology diagnostics available to a broader patient population.
Key Features
- FDA-Cleared Deep Learning Engine: The Cardiologs Holter Platform is the first FDA-cleared ECG analysis solution powered by deep learning, providing regulatory-backed AI diagnostic support.
- Automated Arrhythmia Detection: Clinically validated algorithms automatically analyze Holter recordings and flag arrhythmias, dramatically reducing the time cardiologists spend on manual ECG review.
- Cloud-Based Scalable Architecture: Built on cloud technology, the platform scales effortlessly across hospitals and diagnostic labs, enabling high-volume cardiac diagnostics without additional infrastructure investment.
- Comprehensive Clinical Evidence Base: Backed by 20+ publications, 4 patents, and over 200 million ECGs processed, providing clinicians with confidence in the platform's accuracy and reliability.
- Workflow Integration: Integrates advisory AI interpretations directly into clinical workflows, supplementing physician expertise rather than replacing it for safer, faster diagnoses.
Use Cases
- Hospital cardiology departments using the platform to automate Holter ECG pre-screening and reduce technician review time for arrhythmia detection.
- Remote cardiac monitoring service providers scaling diagnostic throughput without proportionally increasing clinical staff.
- Cardiac electrophysiologists leveraging AI-prioritized case queues to focus attention on the most clinically significant ECG findings first.
- Healthcare networks deploying cloud-based ECG analysis across multiple sites to standardize diagnostic quality and speed.
- Clinical research teams utilizing the platform's validated AI outputs and extensive publication base to support cardiology studies and trials.
Pros
- Regulatory Validation: FDA clearance and extensive peer-reviewed clinical validation give healthcare institutions confidence in deploying the AI for real patient diagnostics.
- Dramatic Throughput Increase: Institutions have reported tripling their Holter analysis capacity, enabling faster diagnoses for significantly more patients without proportionally scaling staff.
- Proven at Scale: With over 200 million ECGs processed and 2 million patients diagnosed annually, the platform demonstrates reliability across large and diverse patient populations.
Cons
- Enterprise-Only Pricing: Cardiologs is a professional medical software solution with no publicly available free tier, making it inaccessible for individual practitioners or small clinics with limited budgets.
- Advisory Role Only: AI-generated interpretations are advisory and cannot be used as the sole means of diagnosis, requiring physician oversight for every result and limiting full automation.
- Institution-Specific Results: Clinical performance results may vary between institutions, meaning outcomes validated at one site may not directly translate to another clinical environment.
Frequently Asked Questions
Is the Cardiologs platform FDA cleared?
Yes. The Cardiologs Holter Platform is the first FDA-cleared ECG analysis solution powered by deep learning technology, making it suitable for clinical use in the United States and other regulated markets.
Can Cardiologs AI replace a cardiologist's interpretation?
No. The platform's AI interpretations are advisory only and are intended to assist, not replace, physicians. They must always be used in conjunction with a clinician's knowledge, patient history, and clinical judgment.
What types of ECG recordings does Cardiologs support?
Cardiologs primarily focuses on Holter (ambulatory) ECG monitoring, providing automated analysis for long-duration cardiac recordings used to detect arrhythmias and other cardiac conditions.
How does Cardiologs integrate into existing clinical workflows?
The cloud-based platform is designed to integrate with existing cardiac diagnostic workflows, delivering AI-generated pre-screening and analysis results that clinicians can review and validate within their standard process.
How many patients has the Cardiologs platform helped diagnose?
As of its most recent disclosures, the Cardiologs platform has processed over 200 million ECGs and helps diagnose more than two million patients per year across institutions globally.
